[1]. Relationship Between Adverse Events and Progression-free Survival in Patients Receiving Cabozantinib for Previously Treated Metastatic Renal Cell Carcinoma.
Anticancer research [巻]44 [号]2 [頁]781 -786 （2024年） [査読] 有
[DOI] [2]. Preoperative factors predicting poor therapeutic efficacy of holmium laser enucleation of the prostate in patients with benign prostatic hyperplasia
LUTS-LOWER URINARY TRACT SYMPTOMS [巻]16 [号]4 （2024年） [査読] 有
[DOI] [3]. New horizon of lower urinary tract function revealed by molecular biology 脊髄損傷マウスにおけるKCC2クロライドイオン・トランスポーターのダウンレギュレーションは排尿筋過活動と関連する(Downregulation of KCC2 chloride ion transporter in mice with spinal cord injury is associated with detrusor overactivity)
日本泌尿器科学会総会 (一社)日本泌尿器科学会総会事務局 [巻]111回 [頁]SY37 -SY37-4 （2024年） [査読] 無
[4]. Significance of second progression-free survival in patients with advanced urothelial cancer who received platinum-based combination chemotherapy followed by pembrolizumab.
International journal of urology : official journal of the Japanese Urological Association [巻]30 [号]9 [頁]730 -736 （2023年） [査読] 有
[DOI] [5]. Therapeutic effects of KCC2 chloride transporter activation on detrusor overactivity in mice with spinal cord injury.
American journal of physiology. Renal physiology [巻]324 [号]4 [頁]F353 -F361 （2023年） [査読] 有
[DOI] [6]. Predictive factors of de novo overactive bladder in clinically localized prostate cancer patients after robot-assisted radical prostatectomy.
International journal of urology : official journal of the Japanese Urological Association [巻]30 [号]1 [頁]57 -61 （2023年） [査読] 有
[DOI] [7]. Effects of Changes in Erectile Function After Holmium Laser Enucleation of the Prostate on Postoperative Outcomes in Patients With Benign Prostatic Hyperplasia.
In vivo (Athens, Greece) [巻]36 [号]6 [頁]2960 -2964 （2022年） [査読] 有
[DOI] [8]. Significant impact of a history of prior or concomitant upper urinary tract cancer on the recurrence and progression of non-muscle invasive bladder cancer.
Japanese journal of clinical oncology [巻]52 [号]8 [頁]944 -949 （2022年） [査読] 有
[DOI] [9]. Prognostic assessments in patients with upper tract urothelial carcinoma undergoing radical nephroureterectomy and systematic regional lymph node dissection.
Urologia [巻]89 [号]3 [頁]354 -357 （2022年） [査読] 有
[DOI] [10]. Feasibility of interaortocaval clamping for renal artery during robot-assisted right partial nephrectomy: A propensity score-matching analysis.
Asian journal of endoscopic surgery [巻]15 [号]3 [頁]531 -538 （2022年） [査読] 有
[DOI] [11]. Initial experience of robot-assisted radical nephrectomy in Japan: Single institutional study of 12 cases
Asian Journal of Endoscopic Surgery John Wiley & Sons Australia, Ltd [巻]15 [号]1 [頁]162 -162-167 （2022年） [査読] 有
[DOI] [12]. Impact of Bladder Neck Angle Measured by Postoperative Magnetic Resonance Imaging on Midterm Recovery of Urinary Continence in Prostate Cancer Patients Undergoing Robot-Assisted Radical Prostatectomy.
Journal of endourology [巻]35 [号]11 [頁]1610 -1615 （2021年） [査読] 有
[DOI] [13]. Health-Related Quality of Life in Patients with Small Renal Mass Who Underwent Robot-Assisted Partial Nephrectomy: A Prospective Evaluation.
Journal of endourology [巻]35 [号]11 [頁]1644 -1649 （2021年） [査読] 有
[DOI] [14]. Prognostic significance of third-line treatment for patients with metastatic castration-resistant prostate cancer: comparative assessments between cabazitaxel and other agents.
International journal of clinical oncology [巻]26 [号]9 [頁]1745 -1751 （2021年） [査読] 有
[DOI] [15]. Molecular Mechanism Mediating Cytotoxic Activity of Cabazitaxel in Docetaxel-resistant Human Prostate Cancer Cells.
Anticancer research [巻]41 [号]8 [頁]3753 -3758 （2021年） [査読] 有
[DOI] [16]. Perioperative outcomes in patients undergoing robot-assisted partial nephrectomy: Comparative assessments between complex and non-complex renal tumors.
Asian journal of endoscopic surgery [巻]14 [号]3 [頁]379 -385 （2021年） [査読] 有
[DOI] [17]. Significance of 5-Aminolevulinic Acid-mediated Photodynamic Diagnosis Following Standard Transurethral Resection in Non-muscle Invasive Bladder Cancer.
Cancer diagnosis & prognosis [巻]1 [号]3 [頁]201 -205 （2021年） [査読] 有
[DOI] [18]. Second transurethral resection for high-risk non-muscle invasive bladder cancer patients: a propensity score matched analysis.
Japanese journal of clinical oncology [巻]50 [号]6 [頁]718 -721 （2020年） [査読] 有
[DOI] [19]. Predictive factors for persistence of preoperative overactive bladder symptoms after transvaginal mesh surgery in women with pelvic organ prolapse.
Lower urinary tract symptoms [巻]12 [号]2 [頁]167 -172 （2020年） [査読] 有
[DOI] [20]. Enhanced Sensitivity to NVP-BEZ235 by Inhibition of p62/SQSTM1 in Human Bladder Cancer KoTCC-1 Cells Both and .
In vivo (Athens, Greece) [巻]34 [号]3 [頁]1001 -1008 （2020年） [査読] 有
[DOI] [21]. Assessment of Factors Predicting Disease Progression in Japanese Patients With Non-Metastatic Castration-resistant Prostate Cancer.
Anticancer research [巻]40 [号]2 [頁]1101 -1106 （2020年） [査読] 有
[DOI] [22]. Complete response to combination therapy with nivolumab and ipilimumab for metastatic collecting duct carcinoma of the kidney.
International cancer conference journal [巻]9 [号]1 [頁]32 -35 （2020年） [査読] 有
[DOI]